Skip to content

Kevin Feeley, Chief Financial Officer at GeneDx, sold WGS on Sep 16, 2026

Data as of Oct 16

▼ SELL$5K52 shares at $95.41Kevin Feeley Chief Financial OfficerWGS GeneDx Holdings Corp.
Watch WGS
Traded
Sep 16, 2026
Disclosed
Sep 18, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kevin Feeley, Chief Financial Officer at GeneDx, sold WGS on Sep 16, 2026TRADEDDISCLOSED
WGSSimilar stocks (XLV — its sector index fund), rebased to WGS's price on the disclosure day
WGS since disclosure
−37.1%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKevin Feeley Chief Financial OfficerWGS GeneDx Holdings Corp.$52.4Kdisclosed Sep 18 · filed 2 days after the trade
  2. ▼ SELLKevin Feeley Chief Financial OfficerWGS GeneDx Holdings Corp.$107Kdisclosed Sep 18 · filed 2 days after the trade
  3. ▼ SELLKevin Feeley Chief Financial OfficerWGS GeneDx Holdings Corp.$55.2Kdisclosed Sep 18 · filed 2 days after the trade
  4. ▼ SELLKevin Feeley Chief Financial OfficerWGS GeneDx Holdings Corp.$144Kdisclosed Sep 18 · filed 2 days after the trade

See every trade on WGS →